Enlyton's Unattributed VC Round

Enlyton raised a round of funding on January 05, 2018. Investors include East Sunshine Foresight Fund.

Enlyton is integrating proprietary antibody technology into cancer-specific, antigen-directed targeting agents for use in cancer imaging, intraoperative cancer detection, and post-operative disease pr…

Articles about Enlyton's Unattributed VC Round: